Outset Medical (OM) Net Cash Flow (2019 - 2026)

Outset Medical (OM) has 8 years of Net Cash Flow data on file, last reported at -$4.4 million in Q1 2026.

• On a quarterly basis, Net Cash Flow rose 90.76% year-over-year to -$4.4 million in Q1 2026; TTM through Mar 2026 was -$44.9 million, a 202.55% decrease from a year earlier, with the FY2025 full-year figure at -$88.5 million, down 259.46% from the prior year.
• Net Cash Flow for Q1 2026 stood at -$4.4 million, down from -$931000.0 in the prior quarter.
• Over the last five years, Net Cash Flow for OM reached as high as $90.7 million in Q4 2024 and fell as low as -$68.0 million in Q1 2022.
• Historically, Net Cash Flow has averaged -$10.7 million across 5 years, with a median of -$4.6 million in 2024.
• On a YoY basis, Net Cash Flow climbed as much as 28315.0% in 2024 and fell as far as 4924.18% in 2024.
• Year by year, Net Cash Flow stood at -$20.7 million in 2022, then soared by 255.95% to $32.2 million in 2023, then surged by 181.66% to $90.7 million in 2024, then tumbled by 101.03% to -$931000.0 in 2025, then tumbled by 377.34% to -$4.4 million in 2026.
• Per Business Quant data, the three most recent Net Cash Flow figures were -$4.4 million in Q1 2026, -$931000.0 in Q4 2025, and -$3.1 million in Q3 2025.